Figure 16.
Annual trends for the treatment of hepatocellular carcinoma (1981–2013, Osaka Red Cross Hospital, Japan). MTT, molecular-targeted therapy; PEI, percutaneous ethanol injection; PMCT, percutaneous microwave coagulation therapy; RFA, radiofrequency ablation; SR, surgical resection; TACE, transcatheter arterial chemoembolization; TAI, transcatheter arterial infusion chemotherapy.